Matches in Wikidata for { <http://www.wikidata.org/entity/Q66397560> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q66397560 description "clinical trial" @default.
- Q66397560 description "ensayu clínicu" @default.
- Q66397560 description "klinisch onderzoek" @default.
- Q66397560 description "клінічне випробування" @default.
- Q66397560 name "Safety, Tolerability & Efficacy on LDL-C of Evolocumab in Subjects With HIV & Hyperlipidemia/Mixed Dyslipidemia" @default.
- Q66397560 name "Safety, Tolerability & Efficacy on LDL-C of Evolocumab in Subjects With HIV & Hyperlipidemia/Mixed Dyslipidemia" @default.
- Q66397560 type Item @default.
- Q66397560 label "Safety, Tolerability & Efficacy on LDL-C of Evolocumab in Subjects With HIV & Hyperlipidemia/Mixed Dyslipidemia" @default.
- Q66397560 label "Safety, Tolerability & Efficacy on LDL-C of Evolocumab in Subjects With HIV & Hyperlipidemia/Mixed Dyslipidemia" @default.
- Q66397560 prefLabel "Safety, Tolerability & Efficacy on LDL-C of Evolocumab in Subjects With HIV & Hyperlipidemia/Mixed Dyslipidemia" @default.
- Q66397560 prefLabel "Safety, Tolerability & Efficacy on LDL-C of Evolocumab in Subjects With HIV & Hyperlipidemia/Mixed Dyslipidemia" @default.
- Q66397560 P1132 Q66397560-B4D35A5A-CAA0-4AEC-9673-AF97D12C3F08 @default.
- Q66397560 P1476 Q66397560-ABB14CC5-145A-4AF6-A9DF-159483E86ADA @default.
- Q66397560 P17 Q66397560-0AC5EB87-7B45-4B30-AB32-41E62A131E65 @default.
- Q66397560 P17 Q66397560-3C50668E-6940-4502-AFEC-93902ADCD87F @default.
- Q66397560 P17 Q66397560-427B8385-4DB7-4FB8-B58E-DAB77021C839 @default.
- Q66397560 P17 Q66397560-47176E6B-8C67-45A4-8EDA-92849783C812 @default.
- Q66397560 P17 Q66397560-4D8E1D19-E6E0-4CAD-9696-E1E7B79B3998 @default.
- Q66397560 P17 Q66397560-605358B2-A1E7-4500-9C63-0F4BC9BD4081 @default.
- Q66397560 P17 Q66397560-641A04AE-8E6A-4883-99A4-7BF5C1FCAA49 @default.
- Q66397560 P17 Q66397560-8AA713BF-E693-4047-A40B-BE43AF198285 @default.
- Q66397560 P17 Q66397560-912C6DA6-3E67-4C62-82F9-68CA27CB6153 @default.
- Q66397560 P17 Q66397560-A890A44A-464E-4416-BADD-080FDF0145E2 @default.
- Q66397560 P17 Q66397560-AA91CBF1-C824-4CCF-B877-07EBF2532230 @default.
- Q66397560 P17 Q66397560-B2499B4C-CEFE-42CC-93D2-401D935620B5 @default.
- Q66397560 P17 Q66397560-B8280B10-7539-4D83-ADFD-37190704E062 @default.
- Q66397560 P17 Q66397560-C791B9B2-C0B0-4603-9C58-7440149D9B79 @default.
- Q66397560 P17 Q66397560-CBAF7DFD-33E3-41A9-9210-5E4B3D50AF74 @default.
- Q66397560 P2899 Q66397560-5D0B94E9-39B8-4F49-BA0E-2363EC809AFA @default.
- Q66397560 P3098 Q66397560-62B0CFFD-00FF-42BD-AA2F-E0CB6A5E6DE2 @default.
- Q66397560 P31 Q66397560-3348CB21-2E4D-4863-93D2-FBCCF5992E0E @default.
- Q66397560 P580 Q66397560-8FD4CB2E-39A3-459E-BA50-1E715350F3FF @default.
- Q66397560 P582 Q66397560-A9FFCE38-FD1F-444D-8E90-345606A8E7AF @default.
- Q66397560 P6099 Q66397560-29D259EA-8ED2-488E-BD30-8853DB566993 @default.
- Q66397560 P8363 Q66397560-67E15945-205F-45FF-BB8F-8E720B36F595 @default.
- Q66397560 P1132 "+467" @default.
- Q66397560 P1476 "A Double Blind, Randomized, Placebo Controlled, Multicenter Study to Evaluate Safety, Tolerability, and Efficacy on LDL-C of Evolocumab (AMG 145) in Subjects With HIV and With Hyperlipidemia and/or Mixed Dyslipidemia" @default.
- Q66397560 P17 Q142 @default.
- Q66397560 P17 Q145 @default.
- Q66397560 P17 Q155 @default.
- Q66397560 P17 Q16 @default.
- Q66397560 P17 Q218 @default.
- Q66397560 P17 Q258 @default.
- Q66397560 P17 Q29 @default.
- Q66397560 P17 Q30 @default.
- Q66397560 P17 Q31 @default.
- Q66397560 P17 Q36 @default.
- Q66397560 P17 Q38 @default.
- Q66397560 P17 Q39 @default.
- Q66397560 P17 Q408 @default.
- Q66397560 P17 Q41 @default.
- Q66397560 P17 Q45 @default.
- Q66397560 P2899 "+18" @default.
- Q66397560 P3098 "NCT02833844" @default.
- Q66397560 P31 Q30612 @default.
- Q66397560 P580 "2017-05-22T00:00:00Z" @default.
- Q66397560 P582 "2019-07-09T00:00:00Z" @default.
- Q66397560 P6099 Q42824827 @default.
- Q66397560 P8363 Q78089383 @default.